| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | X8ZC7V0OX3 |
| InChI Key | DZGWFCGJZKJUFP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C8H11NO |
| Molecular Weight | 137.18 |
| AlogP | 0.89 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 46.25 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 10.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 23 | |
|
Ion channel
Ligand-gated ion channel
5HT3 receptor
|
26000 | - | 8511-8511 | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | 8511-8511 | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Trace amine receptor
|
69 | - | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 60 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Parkinson Disease | 3 | D010300 | ClinicalTrials |
| Hypotension, Orthostatic | 1 | D007024 | ClinicalTrials |
| Orthostatic Intolerance | 1 | D054971 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 51-67-2 |
| ChEBI | 15760 |
| ChEMBL | CHEMBL11608 |
| DrugBank | DB08841 |
| DrugCentral | 2784 |
| EPA CompTox | DTXSID2043874 |
| FDA SRS | X8ZC7V0OX3 |
| Human Metabolome Database | HMDB0000306 |
| Guide to Pharmacology | 2150 |
| KEGG | C00483 |
| PDB | AEF |
| PubChem | 5610 |
| SureChEMBL | SCHEMBL4111 |
| ZINC | ZINC000000002233 |